OVERVIEW OF THE REPROPOSED AND FINAL IND REGULATIONS CONCERNED WITH THE TREATMENT USE AND SALE OF INVESTIGATIONAL NEW DRUGS - THE CONGRESSIONAL PERSPECTIVE

被引：0
|
作者：
EAGLSTEIN, WH
机构：
来源：
FOOD AND DRUG LAW JOURNAL | 1988年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
引用
收藏
页码：435 / 442
页数：8
相关论文
共 5 条
  • [1] PROPOSAL TO AMEND REGULATIONS PERTAINING TO NEW DRUGS FOR INVESTIGATIONAL USE
    BLASINGAME, FJL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 182 (09): : 932 - &
  • [2] THE FDAS NEW PROCEDURES FOR THE USE OF INVESTIGATIONAL DRUGS IN TREATMENT
    YOUNG, FE
    NORRIS, JA
    LEVITT, JA
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (15): : 2267 - 2270
  • [3] Investigational new drugs for the treatment of chronic renal failure: an overview of the literature
    Terzo, Chiara
    Gembillo, Guido
    Cernaro, Valeria
    Longhitano, Elisa
    Calabrese, Vincenzo
    Casuscelli, Chiara
    Peritore, Luigi
    Santoro, Domenico
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (04) : 319 - 334
  • [4] Expanding Patient Access to Investigational New Drugs Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (03): : 403 - 414
  • [5] FDA's Proposed Regulations to Expand Access to Investigational Drugs for Treatment Use: The Status Quo in the Guise of Reform
    Rossen, Benjamin R.
    FOOD AND DRUG LAW JOURNAL, 2009, 64 (01) : 183 - 223
1